Main Content

Traumatic Cervical Spinal Cord Injury

Study title

Phase 2b/3 double blind randomized placebo controlled multicenter study to assess the efficacy and safety of VX-210 in subjects with acute traumatic cervical spinal cord injury

  • Principal Investigator: Dr. Louis Harkey


This study will assess safety and efficacy of an experimental drug in patients with spinal cord injuries.

Who can participate  

Those eligible to participate in this study include:

  • Adults ges 18-75 with an acute spinal cord injury involving cervical spine

For more information

  • Heather Vaughn
    University of Mississippi Medical Center
    2500 N. State St.
    Jackson MS 39216
    (601) 815-8724
  • IRB Number: 2017-0197